Minimally Invasive Surgery Devices Market is Growing Tremendously at a Perfect CAGR of 9.8% During Forecast 2019-2024

Market Overview:

These surgeries are increasingly evolving in the field of ophthalmic, orthopedic, cardiac, oral surgical, and neurological procedures. Thanks to the continuous advancements in the surgical procedures makes it the more efficient and accurate, which boosts their adoption substantially. Thus, the Minimally Invasive Surgery Devices Market valued at USD 20093.4 million and is estimated to expand at a CAGR of 9.8% over the forecast period.
The minimally invasive surgery devices market is getting traction due to increasing geriatric population and increasing prevalence life-threating and chronic diseases. The minimally invasive surgeries are less traumatic and comparatively safer, which makes the healing process faster and less painful. As per the World Health Organization (WHO), the prevalence of chronic diseases is estimated to escalate by 60% by the end of 2020 and 79% of the deaths are caused due to these diseases especially in developing countries.
Additionally, increasing awareness about benefits of the minimally invasive procedures is creating demand and is estimated to remain same in coming years. Further, rising popularity of robotic and non-robotic minimally invasive surgeries are fueling growth of the global minimally invasive surgery devices market.

Browse Full Report Details and TOC Exclusively @ 
https://www.marketresearchfuture.com/reports/minimally-invasive-surgery-devices-market-7875

Competitive Analysis:
·         Abbott
·         Medtronic
·         GE Healthcare
·         Ethicon
·         Siemens Healthcare GmbH
·         Intuitive Surgical
·         ArthroCare Corporation
·         NuVasive
·         DePuy Synthes
·         Biomet
·         KEBOMED Europe AG
·         Norwood Medical

Segmentation:
·         The minimally invasive surgery devices market is segmented based on type, application, end-user, and region.
·         In terms of type, the global minimally invasive surgery devices market is categorized into handheld instruments, cutter instruments, inflation devices, guiding devices, auxiliary devices, electrosurgical devices, and others.
·         In terms of application, the minimally invasive surgery devices market is segmented into cardiac surgery, orthopedic surgery, gastrointestinal surgery, vascular surgery, urological surgery, gynecological surgery, thoracic surgery, dental surgery, cosmetic surgery, and others.
·         In terms of end-user, the minimally invasive surgery devices market is segmented into ambulatory surgical centers, hospitals & clinics, and others.
·         As per the region, the minimally invasive surgery devices market is segmented into Americas, Asia-Pacific, Europe, and the Middle East & Africa.

Regional Analysis:
Regionally, the Americas is estimated to dominate the global minimally invasive surgery devices market owing to large patient pool, high healthcare investment, and well-developed infrastructure. Additionally, growing government funding backing for adoption of advanced healthcare facilities for the several life-threating diseases are benefiting growth of the global minimally invasive surgery market. The market in Europe is estimated to secure second leading position in terms of revenue.
However, Asia Pacific is predicted to expand at a highest CAGR in coming future due to substantial rise in patient pool, presence of large population, growth in government investments. Rise in geriatric population which is prone for several diseases which creates need for development of better facilities in the region. Additionally, emerging economies in the region are investing more for improvement in healthcare infrastructure and adoption of advanced surgical devices.

Industry News:
Increasing approvals and accreditation from the U.S. Food and Drug Administration (FDA) for newer devices is benefiting growth of the market. For instance, Active Implants, LLC received Breakthrough Device Designation from the FDA for its meniscus replacement device.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more